Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby Prolonged-release Chewable Tablets, El(26)a/36

Tuzulby Recall Summary Neuraxpharm UK Ltd has recalled certain batches of Tuzulby prolonged-release chewable tablets (20mg, 30mg, and 40mg strengths) in the UK because safety information is missing from the patient information leaflet and product characteristics documents. The recall affects patients who have been prescribed this medication. This is classified as a Class III defect notification.

Recalling firm

Neuraxpharm UK Ltd

Reason

Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.

Classification

Class III

Category

drug recall

Country

United Kingdom

Agency

UK Medicines and Healthcare products Regulatory Agency

Recall date

2026-07-23

Status

Ongoing

Distribution

United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/5e096878-eff6-4ce1-9099-f8755dbdc3e7